First Header Logo Second Header Logo

Connection

Pierre Triozzi to Melanoma, Experimental

This is a "connection" page, showing publications Pierre Triozzi has written about Melanoma, Experimental.
Connection Strength

1.516
  1. Triozzi PL, Aldrich W, Achberger S, Ponnazhagan S, Alcazar O, Saunthararajah Y. Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing mice. Cancer Immunol Immunother. 2012 Sep; 61(9):1441-50.
    View in: PubMed
    Score: 0.404
  2. Alcazar O, Achberger S, Aldrich W, Hu Z, Negrotto S, Saunthararajah Y, Triozzi P. Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo. Int J Cancer. 2012 Jul 01; 131(1):18-29.
    View in: PubMed
    Score: 0.392
  3. Triozzi PL, Aldrich W, Ponnazhagan S. Regulation of the activity of an adeno-associated virus vector cancer vaccine administered with synthetic Toll-like receptor agonists. Vaccine. 2010 Nov 23; 28(50):7837-43.
    View in: PubMed
    Score: 0.369
  4. Triozzi PL, Aldrich W. Effects of interleukin-1 receptor antagonist and chemotherapy on host-tumor interactions in established melanoma. Anticancer Res. 2010 Feb; 30(2):345-54.
    View in: PubMed
    Score: 0.351
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.